Clinical Trial Update: BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 trial of vandetanib (ZD6474) in previously treated non-small cell lung cancer has completed enrollment, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Vandetanib (ZD6474) (vandetanib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-03-23